/biz/ - Business & Finance

Please, consider buying G1 Therapeutics, Inc. (GTHX). It is a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer.

Feb 12 FDA approved potential blockbuster drug created by this company. This drug is groundbreaking and has no competitors.
Cosela (trilaciclib) is the first therapy in its class to "reduce the frequency of chemotherapy-induced bone marrow suppression in adults receiving certain types of chemotherapy for extensive-stage (when the cancer has spread beyond the lungs) small cell lung cancer."

This stock is criminally underrated. It has 60 average analyst price target, 41 low and 84 high. There is absolutely nothing wrong with it. There is nothing to stop this company from applying for FDA approval to treat other types of cancer and from going international. It has no competition. It will save lives and people will absolutely pay dearly to prolong their live. Chemotherapy is not a good thing for your health and could only be considered as "better than cancer".

But after FDA approval this stock was just destroyed and shoved to the ground. It's absolutely disgusting market manipulation. Look at options. Someone sold shitton of call options expiring this day and he doesn't want to deliver. He will try to keep price lower than $30 or even $25 before market close. It also has a huge short interest (19.42% of free float). Shorters will have to buy it.

I just recommend everyone to put some buy orders at 25-27 to get x2-x4 by the end of the year. Short term I expect it to jump 30-35 next week.